| Product Code: ETC7212122 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, France continued to rely heavily on imports of alpha emitters, with top exporters being Sweden, Czechia, Germany, USA, and Poland. The market remained highly concentrated, as indicated by the high Herfindahl-Hirschman Index (HHI). However, the industry experienced a significant decline in both the compound annual growth rate (CAGR) from 2020-24 at -8.3% and the growth rate from 2023-24 at -50.06%. This suggests challenges and potential shifts in the market dynamics, warranting further analysis to understand the underlying factors driving these trends.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Alpha Emitter Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Alpha Emitter Market Revenues & Volume, 2021 & 2031F |
3.3 France Alpha Emitter Market - Industry Life Cycle |
3.4 France Alpha Emitter Market - Porter's Five Forces |
3.5 France Alpha Emitter Market Revenues & Volume Share, By Type of Radionuclide, 2021 & 2031F |
3.6 France Alpha Emitter Market Revenues & Volume Share, By Medical Application, 2021 & 2031F |
3.7 France Alpha Emitter Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 France Alpha Emitter Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for cancer treatment utilizing alpha emitters |
4.2.2 Growing investments in research and development of alpha emitter therapies |
4.2.3 Rising prevalence of cancer cases in France |
4.3 Market Restraints |
4.3.1 Stringent regulatory approval processes for alpha emitter products |
4.3.2 High cost associated with alpha emitter therapies |
4.3.3 Limited availability of skilled healthcare professionals for administering alpha emitter treatments |
5 France Alpha Emitter Market Trends |
6 France Alpha Emitter Market, By Types |
6.1 France Alpha Emitter Market, By Type of Radionuclide |
6.1.1 Overview and Analysis |
6.1.2 France Alpha Emitter Market Revenues & Volume, By Type of Radionuclide, 2021- 2031F |
6.1.3 France Alpha Emitter Market Revenues & Volume, By Astatine, 2021- 2031F |
6.1.4 France Alpha Emitter Market Revenues & Volume, By Radium, 2021- 2031F |
6.1.5 France Alpha Emitter Market Revenues & Volume, By Actinium, 2021- 2031F |
6.1.6 France Alpha Emitter Market Revenues & Volume, By Lead, 2021- 2031F |
6.1.7 France Alpha Emitter Market Revenues & Volume, By Bismuth, 2021- 2031F |
6.1.8 France Alpha Emitter Market Revenues & Volume, By Others, 2021- 2031F |
6.2 France Alpha Emitter Market, By Medical Application |
6.2.1 Overview and Analysis |
6.2.2 France Alpha Emitter Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.2.3 France Alpha Emitter Market Revenues & Volume, By Bone Metastasis, 2021- 2031F |
6.2.4 France Alpha Emitter Market Revenues & Volume, By Ovarian Cancer, 2021- 2031F |
6.2.5 France Alpha Emitter Market Revenues & Volume, By Pancreatic Cancer, 2021- 2031F |
6.2.6 France Alpha Emitter Market Revenues & Volume, By Endocrine Tumors, 2021- 2031F |
6.2.7 France Alpha Emitter Market Revenues & Volume, By Others, 2021- 2031F |
6.3 France Alpha Emitter Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 France Alpha Emitter Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 France Alpha Emitter Market Revenues & Volume, By Medical Research Institutions, 2021- 2031F |
6.3.4 France Alpha Emitter Market Revenues & Volume, By Others, 2021- 2031F |
7 France Alpha Emitter Market Import-Export Trade Statistics |
7.1 France Alpha Emitter Market Export to Major Countries |
7.2 France Alpha Emitter Market Imports from Major Countries |
8 France Alpha Emitter Market Key Performance Indicators |
8.1 Number of clinical trials involving alpha emitter therapies in France |
8.2 Adoption rate of alpha emitter treatments in cancer care centers |
8.3 Investment trends in companies specializing in alpha emitter technologies |
9 France Alpha Emitter Market - Opportunity Assessment |
9.1 France Alpha Emitter Market Opportunity Assessment, By Type of Radionuclide, 2021 & 2031F |
9.2 France Alpha Emitter Market Opportunity Assessment, By Medical Application, 2021 & 2031F |
9.3 France Alpha Emitter Market Opportunity Assessment, By End User, 2021 & 2031F |
10 France Alpha Emitter Market - Competitive Landscape |
10.1 France Alpha Emitter Market Revenue Share, By Companies, 2024 |
10.2 France Alpha Emitter Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |